Agilik + standard care for cerebral palsy

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Feb 2023: Trial registered, NCT05746871
  2. 2 Mar 2023: Trial started, NCT05746871
  3. 31 Dec 2025: Trial terminated, NCT05746871

The trials

NCT05746871: Safety and Performance of Agilik in CP

State
Stopped early
Phase
No phase
People
9 taking part
Started
2 Mar 2023
Primary completion
31 Dec 2025
Arms
GroupA_Agilik first, GroupB_standard care first
Results
None posted
  1. 28 Feb 2023: Trial registered
  2. 2 Mar 2023: Trial started
  3. 31 Dec 2025: Trial terminated

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.